XBIOTECH
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies. The Company’s lead product candidate inhibits chronic (sterile) inflammation – a condition involved in the progression of many serious and common diseases. The Company has several groundbreaking clinical trial programs in different areas of medicine including dermatology, oncology, diabetes, cachexia and cardiovascular disease.
XBIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.xbiotech.com
Total Employee:
51+
Status:
Active
Contact:
512-386-2900
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default LetsEncrypt Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps ReCAPTCHA
Similar Organizations
AtheroGenics
AtheroGenics is a pharmaceutical company developing Antioxidants.
Braasch Biotech LLC
Braasch Biotech LLC is a biopharmaceutical company working exclusively with therapeutic vaccines.
ImmunoGenes
ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
POINT Biomedical
Point Biomedical is a pharmaceutical company developing technologies for imaging and drug deliveries.
Quorum Innovations
Quorum Innovations is a biopharmaceutical company that focuses on developing human microbiome therapeutics.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.xbiotech.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.94 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "XBiotech"
XBiotech
XBiotech is a biotechnology company focused on developing innovative therapies using True Human antibodies.See details»
XBiotech - Crunchbase Company Profile & Funding
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies. The Company’s lead product candidate inhibits chronic (sterile) inflammation – a condition involved …See details»
Investor Overview | XBiotech USA, INC.
5 days ago XBiotech is a fully integrated biosciences company dedicated to the discovery and development of therapeutic antibodies derived from natural human immunity. Mar 19, 2025 …See details»
XBiotech USA, Inc. | LinkedIn
XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Humanâ„¢ …See details»
XBiotech - businessabc.net
Feb 20, 2025 XBiotech was founded in 2007 by John Simard, a physician-scientist with an entrepreneurial spirit. Headquartered in Austin, Texas, XBiotech has grown to over 200 …See details»
Financial Information | XBiotech USA, INC.
The Investor Relations website contains information about XBiotech USA, INC.'s business for stockholders, potential investors, and financial analysts.See details»
XBiotech Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 XBiotech has 5 employees at their 1 location and $4.01 m in annual revenue in FY 2022. See insights on XBiotech including office locations, competitors, revenue, financials, …See details»
XBiotech - Contacts, Employees, Board Members, Advisors & Alumni
XBiotech is a biopharmaceutical company developing antibody therapies. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered by AI . …See details»
XBiotech - Funding, Financials, Valuation & Investors - Crunchbase
Apr 14, 2015 XBiotech is a biopharmaceutical company developing antibody therapies. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
XBiotech - Products, Competitors, Financials, Employees, …
XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs …See details»
XBiotech USA - Overview, News & Similar companies - ZoomInfo
Who is XBiotech USA. XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic a ntibodies based …See details»
XBiotech Inc. (XBIT) Company Profile & Facts - Yahoo Finance
See the company profile for XBiotech Inc. (XBIT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
XBiotech | Austin TX - Facebook
XBiotech is a fully integrated biopharmaceutical that uses proprietary technology to create True Humanâ„¢ monoclonal antibody medicines. True Humanâ„¢ antibodies harness natural immunity …See details»
XBiotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
XBiotech is pioneering the discovery and development of targeted antibodies based on its True Humanâ„¢ technology. The company’s mission is to rethink the way antibody medicines are …See details»
XBiotech Inc. (XBIT) Stock Price, News, Quote & History - Yahoo …
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on …See details»
XBiotech Pauses Rheumatology program | XBiotech USA, INC.
Dec 23, 2024 XBiotech was planning launch of additional studies in arthritis as well as other areas of rheumatology, including ankylosing spondylitis, which are now on hold while recent …See details»
Xbiotech Inc (XBIT-Q) Stock Price and News - The Globe and Mail
Real-time Price Updates for Xbiotech Inc (XBIT-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
Alvotech Acquires Xbrane’s R&D Operations in Sweden and …
5 days ago Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today …See details»
XBiotech Announces Successful Completion of Phase I portion of ...
Jun 20, 2022 XBiotech is currently advancing a robust pipeline of antibody therapies to redefine the standards of care in oncology, inflammatory conditions, and infectious diseases. …See details»
Alvotech Acquires Xbrane’s R&D Operations in Sweden
5 days ago REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and …See details»